SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice

Cardiovascular disease (CVD), including heart failure (HF), is a leading cause of morbidity and mortality in people with type 2 diabetes mellitus (T2DM). CVD and T2DM share common risk factors for development and progression, and there is significant overlap between the conditions in terms of worsen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Ther
Main Authors: Ali, Amar, Bain, Steve, Hicks, Debbie, Newland Jones, Phillip, Patel, Dipesh C., Evans, Marc, Fernando, Kevin, James, June, Milne, Nicola, Viljoen, Adie, Wilding, John
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare 2019
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6778582/
https://ncbi.nlm.nih.gov/pubmed/31290126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-019-0657-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados